Announcement on Conversion Result of Convertible Bonds and Share Changes
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Conversion Result of Convertible Bonds and Share Changes
Filed with SSE · · 4 pages · Chinese
Release
DaShenLin Pharmaceutical Group Co., Ltd. on 6ix
Earlier from DaShenLin Pharmaceutical
- Announcement on Progress in Providing Guarantee for Subsidiary
- in 2026
- Announcement on Adjustment of the Conversion Price of the “Dashenlin Convertible Bonds"
- Indicative Announcement on Suspending Conversion of “Dashenlin Convertible Bonds" during the Implementation of Dividend Distribution for 2025
- Indicative Announcement on Impending Expiration of 2020 Employee Stock Ownership Plan
Later from DaShenLin Pharmaceutical
- Announcement on Reply to the Inquiry Letter on the Company's 2025 Annual Report
- Notice on Convening the 2nd Extraordinary General Meeting in 2026
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- First Indicative Announcement on Maturity Redemption and Delisting of "DaShenLin Convertible Bonds"
- Announcement on Convening the 2026 Semi-annual Performance Briefing
Follow DaShenLin Pharmaceutical into a list and get an email when it puts out news.
Follow DaShenLin Pharmaceutical